A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions
Von Willebrand Disease (VWD)
Interventions
BIOLOGICAL

rVWF

Recombinant von Willebrand factor

BIOLOGICAL

rFVIII

Recombinant Factor VIII

Trial Locations (33)

28046

Hospital Universitario La Paz, Madrid

29425

Medical University of South Carolina (MUSC), Charleston

32610

University of Florida College of Medicine, Gainesville

35040

Ege University Medical Faculty, Izmir

35100

Ege University Medical Faculty, Izmir

43205

Nationwide Children's Hospital, Columbus

44106

Rainbow Babies and Children's Hospital, Cleveland

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46026

Hospital Universitari i Politecnic La Fe, Valencia

46260

Indiana Hemophilia and Thrombosis Center, Indianapolis

50134

Azienda Ospedaliera Universitaria Careggi, Florence

55139

Ondokuz Mayis Univ. Med. Fac., Samsun

69677

Groupement Hospitalier Est- Hôpital Louis Pradel, Bron

72202

Arkansas Children's Hospital Research Institute, Little Rock

75015

Hôpital Necker - Enfants Malades, Paris

80045

University of Colorado Health, Aurora

94270

Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre

610017

"FSBI of Science Kirov Scientific and Research Institute of Hematology and Blood Transfusion of FMBA", Kirov

650066

"SAIH Kemerovo Regional Clinical Hospital", Kemerovo

Unknown

AKH - Medizinische Universität Wien, Vienna

Hopital Cardiologique - CHU Lille, Lille

Groupe Hospitalier Pellegrin - Hôpital Pellegrin, Gironde

Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt

Werlhof-Institut GmbH, Hanover

Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan

Azienda Ospedaliera Pediatrica Santobono Pausillipon, Napoli

Ospedale Pediatrico Bambino Gesù, Roma

Istanbul University Oncology Institute, Istanbul

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

00185

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Roma

3015 AA

Erasmus Medisch Centrum, Rotterdam

3015 CN

Erasmus Medisch Centrum, Rotterdam

03010

Hospital General Universitario de Alicante, Alicante

All Listed Sponsors
collaborator

Takeda Development Center Americas, Inc.

INDUSTRY

lead

Baxalta now part of Shire

INDUSTRY

NCT03879135 - A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD) | Biotech Hunter | Biotech Hunter